Comparative Analysis of the Efficacy of Different Regimens of 12 Months Rifaximin-Alfa Therapy in Patients with Liver Cirrhosis and Minimal Hepatic Encephalopathy

Comparative Analysis of the Efficacy of Different Regimens of 12 Months Rifaximin-Alfa Therapy in Patients with Liver Cirrhosis and Minimal Hepatic Encephalopathy

It is a matter of current interest which rifaximin-α regimens in patients with liver cirrhosis and minimal hepatic encephalopathy are the most efficient. Study objective: to evaluate the effect of various rifaximin-α regimens for 12 months on clinical and laboratory parameters and quality of life in...

Full description

Bibliographic Details
Main Authors: Igor G. Bakulin, Kristina N. Ivanova, Elena Y. Eremina, Natalya V. Marchenko
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Diagnostics
Subjects:
liver cirrhosis
hepatic encephalopathy
minimal hepatic encephalopathy
rifaximin-α
Online Access:https://www.mdpi.com/2075-4418/13/20/3239

Internet

https://www.mdpi.com/2075-4418/13/20/3239

Similar Items